Omalizumab in middle-aged or older patients with severe allergic asthma-COPD overlap

INTRODUCTION: Biological therapies used for severe asthma may be useful even for middle-aged or older patients who have a history of severe allergic asthma with a chronic obstructive pulmonary disease (COPD) overlap phenotype. AIM: To show omalizumab efficacy in severe allergic asthma-COPD overlap d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricciardi, Luisa, Papia, Francesco, Liotta, Marta, Cicero, Francesca, Isola, Stefania, Tartarisco, Gennaro, Furci, Fabiana, Gangemi, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953889/
https://www.ncbi.nlm.nih.gov/pubmed/35369622
http://dx.doi.org/10.5114/ada.2022.113804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953889/
https://www.ncbi.nlm.nih.gov/pubmed/35369622
http://dx.doi.org/10.5114/ada.2022.113804

Ejemplares similares